Introduction
The life cycle of herpes simplex virus (HSV) has two distinct phases: lyric and latent (Roizman & Sears, 1990; Stevens, 1989) . During its lyric phase, HSV-1 expresses three temporally regulated classes of genes, immediate-early (IE), early and late (Honess & Roizman, 1974) . Viral replication and lytic gene expression are decreased upon infection of sensory neurons leading to the onset of latency, during which the only abundant gene products are the latency-associated transcripts (LATs) (Stevens et al., 1987) . Periodically, HSV-1 may reactivate with or without the production of lesions at the site of primary infection (Stevens, 1989) .
The first proteins synthesized during lytic infection are the IE class which have either regulatory or immunomodulatory Author for correspondence: David A. Leib Fax + 1 314 362 3638. e-mail Leib@am.seer.wusti.edu.us functions (reviewed in Roizman & Sears, I990; York et aL, 1994) . Infected cell protein 0 (ICP0 also known as Vmw 110), the focus of this study, is not required for replication but confers a growth advantage especially at low m.o.i. (Cai & Schaffer, 1992; Sacks & Schaffer, 1987; Stow & Stow, 1986) . ICP0 viral mutants grow inefficiently in vivo and are impaired in their ability to reactivate from latency (Cai eta]., 1993; Clements & Stow, 1989; Leib eta] ., 1989). ICP0 is a 775 amino acid nuclear phosphoprotein which transactivates a variety of HSV-1 promoters either alone or synergistically with ICP4 (Cai & Schaffer, 1989; Everett, 1984; Gelman & Silverstein, 1986; Quinlan & Knipe, 1985) . Replication and reactivation efficiencies of viruses expressing mutant forms of ICP0 correlate with the transactivation activities of corresponding ICP0 mutants in transient expression assays (Cai eta]., 1993) . This suggests that the transactivation function of ICP0 is important for viral growth and reactivation. The mechanism of transactivation by ICPO is unknown although ICP0 interacts with a 135 kDa cellular protein (Meredith eta] ., I994) and with ICP4 and ICP27 (Zhu eta]., 1994) . Complex interactions with viral and cellular factors therefore regulate ICP0 activity.
A number of transcription factors and cis-acting elements regulate ICP0 and other IE genes. The virion protein VP16 and cellular factors Oct-1 and HCF upregulate the transcription of all IE genes upon infection via cis-acting 5' TAATGARAT 3' motifs (Kristie & Roizman, 198 7; McKnight eta] ., 1987) . The transactivation domain of VP16 is, however, dispensable for efficient viral reactivation (Steiner et al., I990) .
The cellular transcription factor Spi also upregulates the expression of IE genes (Jones & Tjian, 1985) . Canonical ICP4-binding sites (Faber & Wilcox, 1986) are found in the ICP0 and ICP4 promoters, although viruses with mutations in these sites do not exhibit significantly altered levels of ICP0 or ICP4 (Everett & Orr, 1991; Smith et aL, 1989) . One or both of two cellular factors, a CA_AT-enhancer binding protein and an undefined binding factor termed F2, which bind overlapping sites at position -89 to -74 from the transcriptional start site, are important in the transcriptional activation of ICP0 in HeLa ceils (O'Rourke & O'Hare, 1993) . Another study indicated that the region from -550 to -I29 is required to induce ICP0 expression after transfected cells are released from growth arrest (Ralph et aI., 1994) .
Transient expression assays have elucidated cis-acting elements and their cognate trans-acting factors. It is clear, however, that such assays do not always reflect mechanisms in the context of the virus (Everett & Orr, 1991; Rader et aI., 1993) . Indeed, little is known about the cis-acting elements necessary for ICP0 expression, or for the establishment and reactivation of latency. In this study, a viral mutant was constructed which has a deletion from -420 to -70 relative to the transcriptional start site of ICP0. This virus displayed decreased ICP0 expression in cell culture and correspondingly decreased virulence in mice. However, the establishment of and reactivation from latency were unaffected. These data demonstrate that promoter elements which are important for ICP0 expression and virulence are dispensable for the establishment of latency and for efficient reactivation.
Methods
• Cells and viruses. African green monkey kidney (Vero) cells were propagated as described (Rader et al., 1993) . VeroICP6LacZ#7 cells, provided by Paul Olivo, Washington University (Tebas eta]., 1995) were propagated as for Vero cells supplemented with 400 ~g/ml G418. L7, a stable Vero cell line expressing ICP0, 4 and 27 (provided by Nea[ DeLuca, University of Pittsburgh) was propagated in 200 ~g/ml G418. Propagation, assay and growth curves of HSV-1 strain KOS, dlx3.I (ICP0 null mutant; Sacks & Schaffer, 1987) and recombinant viruses constructed in this study were performed as described (Rader et al., 1993) .
• Plasmids. Enzymes were purchased from New England Biolabs and used according the manufacturer's instructions, pSP0, which contains the ICP0 promoter, was created by digesting pSG2~ (Sandri-Goldin et aI., I98I) with Xhal and DraI and [igat~ng the resulting 3"0 kb fragment into pSP72 (Promega) digested with XhoI and EcoRV. pSPOT differs from pSP0 by the addition of an 89 bp SphI-SalI fragment of the tetracyclineresistance gene (pBR322) blunt-ended with Klenow and ligated into the unique StuI site of the ICP0 promoter, pSPOT-ATfi was created as follows: first, pSPOT was digested with TfiI, blunt-ended with Klenow fragment, digested with XhoI and a 1'3 kb fragment isolated; second, pSPOT was digested with BstXI, blunt-ended with T4 DNA polymerase, digested with XhoI and a 3"8 kb fragment isolated. The two fragments were subsequently l/gated, deleting the promoter from -420 to -70 relative to the [CP0 transcriptional start site (Fig. 1) . The following plasmids were utilized for RNase protection assay: pD~i (ICP0 probe) is a NcoI-NotI I kb fragment of pSPOT cloned into pGem-Szf(--) (Promega). pRP27
(ICPS/UL28/gB probe) is a SacI-SalI fragment (1-5 kb) of BamHI fragment G of HSV-1 strain McKrae cloned into the same sites of pGem3zf( -) (Promega). pTT-ISS-rRNA (18S rRNA probe) was obtained from Ambion (Austin, Texas).
• Generation of recombinant viruses, pSPOT-ATfi Iinearized with Xh~I was cotransfected with infectious HSV-1 KOS DNA into Veto cells using Lipofectin (Gibco-BRL). Progeny viruses were plated onto Vero cells, overlaid with DMEM/methylcellulose and stained with neutral red.
Plaques were picked into 48-well plates (Falcon; Becton-Dickinson), harvested upon complete CPE and the plates frozen at -80 °C. Viral DNA was prepared (Rader eta] ., 1993) and loaded onto a DNA slot blotter (Schleicher & Schuell) according to the manufacturer's instructions. The nitrocellulose filter was probed with a ~2P-Iabelled tetracyclineresistance gene fragment (BamHI-Sa]I of pBR322) and autoradiography was used to identify positive clones which were then plaque-purified. Viral DNA (Rader et aL, 1993) and pSPOT-ATfi were cut with XhoI and Sad, then analysed by Southern blot hybridization. The marker-rescued virus, aTfiR, was created by the cotransfection of linearized pSP0 with infectious aTfi DNA into Vero cells. All viruses were plaque-purified at least three times prior to making stocks.
• RNase protection assay (RPA)/IE gene expression. Expression of ICP0 transcripts was assessed by using Ambion's RPA II kit according to manufacturer's protocol and Ackland-Berglund et al. (1995) .
Cells were infected at an m.o.i, of 5 in the presence of 75 gg/ml of cycloheximide (Honess & Roizman, I973) . DNase-treated cytoplasmic RNA was isolated as described (Strelow & Leib, 1995) using 1/10 of the RNA samples for hybridizations. Antisense RPA probes were created by digestion of the indicated plasmid and then using either T7 (New England BioLabs) or SP6 (Promega) RNA polymerase. For detection of ICPS/gG, pRP27 was digested with Tth111I and run off with Sp6; for the detection of ICP0, pD2i was digested with TfiI and run off with T7. For detection of 18S rRNA, prelinearized pT7-rRNA-18S (Arabian) was run off with T7. The size of full-length probe for ICPS/gB is 317 nt, for ICP0 is 255 nt and for 18S rRNA is 109 nt. The sizes of the protected RNA fragments are listed in the legend to Fig. 3 . Protected RNA fragments were separated on 6% denaturing polyacrylamide gels alongside Century RNA molecular mass markers (Ambion). Gels were dried and exposed to X-OMAT film (Kodak). A Bio-Rad Imaging Densitometer and Molecular Analyst Software were used to analyse the relative amounts of RNA between samples using 18S rRNA as a loading control.
• Immunoblotting. • p-Galactosidase assay. 2 x I0 s VeroICP6LacZ#7 cells per 35 mm dish were plated and infected 24 h later at an m.o.i, of 5. Cells were harvested at 6 or 18 h p.i., washed with PBS three times and harvested in triton/gIycylglycine lysis buffer (1% Triton X-IO0, 25 mM-glycylglycine pH 7'8, 15 mM-MgSO 4, 4 mM-EGTA, 1 mM-DTT) (Brasier et al., 1989) . fl-Galactosidase activity was assayed as previously described (Rouet et al., 1992) . Absorbance values were read at 570 nm on a Molecular Dynamics plate reader and/~-galactosidase activity determined by a linear standard curve.
• Animal procedures (i) Infection of mice, acute titre, pathogenesis and reactivation assays. CD-I mice (21-25 g, Charles River Laboratory) were infected and acute replication assessed on Vero and L7 cells as described (Leib et al., I989) . Alternatively, ganglia were homogenized using i a m beads in a Mini-Beadbeater-8 (Biospec Products, Bartlesville, Okla.). Clinical signs of infection (eyelid swelling and loss of facial hair) were measured in a 'blind' fashion on a semi-quantitative scale of 0 to 4 on day 14 p.i. Twenty-eight days p.i., trigeminal ganglia were removed and explanted as described (Leib et al., I989) . Kinetics of reactivation were examined by dissociation of latently infected trigeminal ganglia as described (Rader e~ al., 1993) and plating samples onto fresh Vero or L7 cell monolayers. CB17 severe combined immunodeficient (SCID) mice (provided by Sam Stanley, Washington University) were bred at Washington University by brother-sister mating. SCID mice were infected intraperitoneally with I00 ~tl of medium containing 2 X 107-4 X i 0 7 p.f.u, of KOS or ATfi based on titres on L7 cells. Time to death was recorded by daily inspection.
(ii) Number of latently infected ganglionic cells. Superinfection assays performed to quantify the number of latently infected ganglionic cells were performed as described (Leib et al., I989) . After 30 min of dissociation, each ganglion was disrupted by pipetting I0 times with a micropipette, an additional I ml of dissociation mixture was added before further digestion at 37 °C for 30 min followed by pelleting, plating, superinfection and plaque assay.
• Analysis of viral DNA in the latent trigeminal ganglion by quantitative PCR. Ganglion DNA was prepared 28-31 days p.i. as described (Katz et al., 1990) . DNA was resuspended in I00 lal of TE (10 mM-Tris-HC1, I mM-EDTA pH 7"5). Primer pairs were used which amplify the thymidine kinase gene of HSV-1 to give a 110 bp product (5' ATACCGACGATATGCGACCT 3' and 5' TTATTGCCGTCATAG-CGCGG 3') (Takasu et al., 1992) , and the mouse adipsin gene (as a loading control) to give a 48bp product (5' AGTGTGCGG-GGATGCAGT 3' and 5' ACGCGAGAGCCCCACGTA 3') (Kafz et al., I990). PCR was performed using 100 ng of ganglion DNA and buffer as previously described (Katz ef al., I990) . Standards containing 100 ng of mouse tail DNA were spiked with 0"016 to 2"0 viral genomes per mouse cell equivalent. Amplifications were done using 100 pmol of each primer per reaction and subjected to 30 cycles of PCR amplification. A hot start at 95 °C for 5 rain was followed by denaturation at 94 °C for 1 min, annealing at 59 °C for 1-5 min, an extension at 74 °C for 2'5 min and a final extension at 72 °C for 7 min. Ten microIitre aliquots of each PCR reaction were loaded on 8 % non-denaturing acrylamide gels, transferred to a nylon filter (Hybond-N +, Amersham) and UV cross-linked (Stratalinker, Stratagene). Filters were prehybridized and then hybridized using 32P-labelled probes internal to the PCR products to detect thymidine kinase (5' CCGGGCAAACGTGCGCG 3') and adipsin (5' AGTCGAAGGTGTGGTTAC 3') (Katz et al., 1990) . Filters were washed and exposed to preflashed Kodak X-OMAT film. Quantification of PCR products was done by densitometry as described for the RPA using the HSV-1 standards to define the linear range.
Results

Promoter mutations and their introduction into the viral genome
The ICPO promoter mutation deleted promoter elements from -420 to -70 upstream of the transcriptional start site of ICP0, leaving the ICP4, Sp1 and T A T A elements intact (Fig.  1) . Tet tag insertion site and 5' deletion limits do not interfere with either the two putative polyadenylation signals of ICP34.5 (Chou & Roizman, 1986) or the minimal promoter of ORF P (Bohenzhy et al., 1995) .
The tetracycline resistance (Tet) fragment was used as a hybridization tag for D N A slot-blot analysis to facilitate screening for recombinants. HSV-Tet was created to ensure that insertion of the Tet fragment alone did not affect viral growth and reactivation. Marker-rescued virus (ATfiR) was created to ensure that secondary mutation was not responsible for the phenotype of ATfi. Southern blot analysis (Fig. 2 ) gave expected fragments of 2'0 kb for KOS and ATfiR, 2"1 kb for HSV-Tet and 1'7 kb for kTfi. Tet-positive clones (for ATfi) were isolated at a frequency of 4 / 1 9 1 (2 %), and ATfiR positive clones were isolated at a frequency of 5 6 / 7 0 (80%), consistent with a growth disadvantage for ICP0 mutant viruses (Cai & Schaffer, 1992; Sacks & Schaffer, 1987; Stow & Stow, 1986) . 
Efficiency of plating (EOP) of recombinant viruses in tissue culture
ICPO expression and activity of •Tfi
ICP0 expression and transactivation activity were examined in Veto cells. Since aTfi lacks four TAATGARAT elements, it was important to determine whether ICP0 was still an IE gene. kTfi was able to synthesize correctly initiated ICP0 transcripts in the presence of cycloheximide, albeit at an average of 2"5-fold lower levels than KOS or aTfiR after normalization to 18S rRNA (Fig. 3) . The deletion of the ICPO promoter therefore did not disrupt its ability to be activated under IE conditions. Transcripts for ICP8 and gB were not detected, demonstrating that cycloheximide blocked early and late gene transcription. $1 nuclease analysis confirmed correct ICP0 transcriptional initiation in the absence of cycloheximide with an RNA signal which was 4-fold lower for aTfi compared to KOS and aTfiR at 3 h p.i. (data not shown). Levels of ICP0 protein were then examined in Vero cells infected at an m.o.i, of 5 with KOS, ATfi, aTfiR or dlxd.1 various times p.i. by immunoblotting (Fig. 4) . The level of ICP0 protein, as determined by densitometric imaging, was barely detectable for ATfi at 6 h p.i. when robust signals were seen for KOS and 5TfiR. At 9 h p.i., the level was 3-fold lower than with KOS and ATfiR, with no significant difference at later time points. As expected, d/xd.1 did not express detectable levels of ICP0.
ICP0 is a potent transactivator of the early gene ICP6 (UL39) (Goldstein & Weller, 1988; Tebas et al., 1995) . To assess ICP0 transactivation of ICP6 quantitatively, a Vero cell line stably transformed with an HSV ICP6 promoter /acZ cassette (Tebas e~ al., 1995) was infected with KOS, ATfi, ATfiR or dlx3.1 at an m.o.i, of 5, or was mock-infected. ATfi induced 3-fold less fl-galactosidase activity at 6 and 18 h p.i. compared to KOS or ATfiR (Fig. 5) . In contrast, dlxd.1 was unable to induce fl-galactosidase activity significantly above the level of mock-infected cells. This reduction in ICP6 transactivation for ATfi therefore correlates with decreased IE ICP0 transcript levels as observed by RPA and decreased levels of protein by immunoblotting at early times p.i.
Replication and virulence of viruses during acute infection in vivo
Acute titres of HSV-Tet were not significantly different from those of KOS in eyes and trigeminaI ganglia on the days assayed ( Table 2 ), demonstrating that the insertion of the Tet DNA tag did not affect viral replication. In contrast, ATfi, showed a 60-to 120-fold reduction of replication in eyes, and 60-to 80-fold reduction in ganglia, on day 3 p.i. relative to KOS and kTfiR (Table 2 ) when assayed on Vero cells. Similar differences between kTfi, and wild-type and marker-rescued viruses were observed in the eyes and ganglia on days 3 to 7 p.i. (data not shown).
One complication with the experiment above is that higher particle-to-p.f.u, ratios and reduced EOPs are observed for ICP0 mutants on Vero cells compared to wild-type virus (Table  1 ; Cai & Schaffer, 1992; Sacks & Schaffer, 1987; Stow & Stow; . It was possible therefore, that aTfi and wild-type viruses were making equivalent numbers of viral particles with a different ability to plaque on Vero cells. To test this, samples of KOS, aTfi and d/xd.I (ICP0 null mutant) from infected eyes and ganglia were assayed in parallel on Vero and L7 cells. To normalize the number of infectious viral particles, mice were infected with 2 x 106 p.f.u, of KOS, ATfi or d/xd.1 per eye based on L7 cell titres. During acute infection aTfi titres in eyes and ganglia were intermediate relative to those of KOS and d/xd.1 when assayed on Vero cells (Table 3) . In contrast, when assayed on L7 cells aTfi titres in eyes and ganglia were comparable to those of KOS. This suggests that comparable numbers of aTfi and KOS infectious viral particles are being produced, but their EOPs on Veto cells differ significantly.
Given that aTfi had a reduced EOP on Vero cells, it was important to determine whether this correlated with altered virulence in mice. KOS, ATfiR and HSV-Tet caused significantly (P < 0"01, x 2) more external pathology (Table 2) than kTfi in terms of eyelid inflammation and removal of hair around the eyes and snout of CD-1 mice (n = 42 for KOS, n = 18 for ATfi, n = 12 for HSV-Tet, n = 6 for kTfiR). This indicated reduced virulence for aTfi and that the insertion of the tetracycline tag did not affect virulence. In immunodeficient (SCID) mice, KOS was also significantly more virulent than ATfi (Table 2 ). All mice (n = 5) died within 13 days following infection with KOS with a mean time to death of 11 days. In contrast, all mice (n = 5) infected with aTfi survived through day 13, with a mean time to death of 18 days, which is significantly different from KOS (P < 0"01, Fisher's exact test). Taken together, these data suggest that although comparable numbers of KOS and kTfi L7 infectious viral particles are made in mice there are qualitative differences between the populations of particles made by these viruses in terms of their ability to cause disease in vivo.
Reactivation of ICPO promoter mutants from latency
In explant cocultivation reactivation assays the reactivation frequency of HSV-Tet was indistinguishable from that of KOS, demonstrating that the Tet DNA tag insertion does not affect reactivation (Table 2 ). In addition, reactivation frequencies of dTfi and dTfiR were not significantly different (P = 0"7, Fisher's exact test) from KOS. Southern blotting of reactivated i i i i i i i ,i i i i i i iii:iiiiiii iii iiii ! i !!i samples revealed that they were identical to input viruses, ruling out reversion or contaminated viral stocks (data not shown). The kinetics of reactivation of KOS, dlTfi and ATfiR were examined in dissociated ganglion cultures. By this method, there was no significant difference between KOS, ATfi and ATfiR, with a mean time to 50% reactivation of approximately 4 days, plating onto Vero or L7 cells giving identical results. Maximal reactivation was accomplished by all viruses with comparable timing. There was also no difference in the kinetics of reactivation when mice were infected with 2 x 106 p.f.u, as based on L7 cell titres. These studies indicate that insertion of DNA at the 5tuI site and the deletion of promoter elements in ATfi do not significantly perturb reactivation in explant or dissociation culture assays.
Ability to establish latency
(i) Viral DNA per ganglion. One possible explanation for the identical reactivation frequencies of aTfi and wild-type viruses was that dlTfi was able to establish a latent infection with higher efficiency than KOS or hTfiR. The amount of viral DNA per latently infected ganglion for each virus was therefore assessed by quantitative PCR. The HSV-1 thymidine kinase gene and the mouse single copy adipsin gene were measured alongside a standard curve. The amount of viral DNA per cell equivalent ranged from 0"07 to 0'3 for KOS, 0"02 to 1"0 for hTfi and 0"04 to 0"4 for dlTfiR (Table 2 ). 5Tfi (P = 0"3) and ATfiR (P = 0"4) were not statistically different from KOS (Mann-Whitney U two-tailed test).
(iO Superinfection assay. A second approach to determine whether ATfi was more efficient in establishing a latent infection than KOS and ATfiR was to measure the relative number of ganglion cells harbouring viral genomes by a superinfection assay. The number of plaques obtained from superinfected ganglia inoculated with aTfi (mean of 86) and ATfiR (mean of 77) were not statistically different (P > 0"05, Mann-Whitney U two-tailed test) from mice infected with KOS (mean of 68). Taken together, these assays demonstrate that establishment of reactivatable latent infections is equivalent among KOS, ATfi, and ATfiR.
Discussion Promoter elements involved in ICPO expression
The primary aim in this study was to determine which cisacting elements are critical for ICP0 expression for efficient replication in vitro and in viva, for pathogenesis and for reactivation. ATfi lacks many cis-acting elements including Spl, NF-KB, C/EBP, F2 and four TAATGARAT sites. The reduced expression of ICP0 RNA, protein and transactivation capability at early times p.i. most likely results from reduced VP16 activation due to deletion of the TAATGARAT and octamer/ TAATGARAT motifs. In spite of this, ICP0 was expressed as an IE gene, suggesting that four identified TAATGARAT elements upstream of the deleted elements are responsive to VP-16 transactivation (Chou & Roizman, 1986; Douville eta] ., 1995; Ralph et aI., I994). These elements may be functional in wild-type virus, or they may have become functional by being brought closer to the ICP0 transcriptional start site by the deletion in ATfi.
The existence of upstream TAATGARATs in the promoter of ATfi, however, cannot explain its unexpected ability to reactivate normally since it has been shown that the activation domain of VP 16 is dispensable for efficient reactivation (Steiner et aI., 1990) . Other elements must therefore be sufficient in this context. It is also possible that other cis-acting elements upstream of the BstXI site have been brought closer to the mRNA start site of ICP0 and can substitute for the deleted promoter elements during reactivation. With regard to this possibility, the tetracycline tag itself does not contain any recognizable elements. The nearest defined viral promoter is ~X (Bohenzhy et al., 1995 ; Lagunoff & Roizman, 1994; Yeh & Schaffer, 1993) which is intact in hTfi and has been shown to drive transcription antisense to ICP34.5, particularly in the absence of ICP4. The precise limits, functions and orientation dependence of ~X and fiX remain to be determined and it is therefore difficult to determine whether the aTfi deIetion can --100 be compensated by these transcriptional units. Another region, from -5 5 0 to -129 relative to the transcriptional start site of ICP0, has transcriptional activity in transient assays following release of cells from growth arrest and has been proposed to play a role in reactivation (Ralph et al., 1994) . The deletion in ATfi, lies between --420 and --70, so if this growth-release activity plays a role in reactivation it must lie between -5 5 0 and -4 2 0 in the ICP0 promoter. Promoter elements in ATfi which remain proximal to the transcriptional start site are the TATA box and the Sp1 and ICP4 binding sites. Further mutagenesis is in progress to better define the roles of these elements. cells, however, ATfi and wild-type titres appear comparable (Table 3 ). It could be concluded from the L7 cell data, therefore, that there is no qualitative or quantitative difference between zXTfi and wild-type virus in terms of yields of infectious virus particles. The observation that ATfi is significantly less virulent, however, argues against this conclusion. The low virulence of ATfi in mice, but equivalence of L7 titres suggests that similar numbers of viral particles are made by zXTfi and wild-type viruses, but the pathogenic and replicative potentials of these KOS 2'9 x 10 ~ 5'7 × I02 1"7 X 1 0 4 1"6 × 1 0 4 ATfi 8"0 x I00 1"9 × 102 1"2 x i0 1"7 X 1 0 4 dlx3.1 4"0 × 100 2"9 x 101 0 6.0 × 101 populations differ in Vero and murine cells which are both noncomplementing. This is consistent with the data in Table i which show that the EOP of ATfi is 4-5-fold lower on Vero and 6-10-fold lower on CdH10T1/2 cells than wild-type or marker-rescued viruses. The cell-cycle dependence of ICPO complementation (Cai & Schaffer, 1991) or the limiting quantities of ICP0 available for packaging into the virion (Yao & Courtney, 1992) , or both these factors, could account for the virulence and plating efficiency defect observed with ATfi. A concern regarding the reduced virulence of ATfi is whether ICP34.5 and ORF P have been adversely affected by the mutation. A number of points argue against this possibility. First, the Tet insertion site and 5' deletion limit in the ICP0 promoter do not delete either the poIyadenylation signals of ICP34.5 (Chou & Roizman, 1986) or a defined promoter (aX) for ORF P (Bohenzhy et aI., 1995) . Second, the EOP deficit of ATfi is complemented by a cell line expressing ICP0, again suggesting that ICP0 is the deficient gene. Finally, ICP34.5 mutants would be expected to exhibit reduced replication in viva (Spivack et al., 1995) which was not observed with either HSV-Tet or ATfi.
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Establishment and reactivation of latency for dTfi
The reduced level of virulence observed for ATfi coupled with the reduced levels of ICP0 expression in cell culture would predict that aTfi would reactivate from latency with reduced efficiency. However, this study indicates that ATfi reactivates comparably to wild-type viruses. Furthermore, PCR analysis and superinfection data demonstrate equivalence of establishment of latency by ATfi and wild-type viruses. This equivalence of establishment of latency despite reduced ICP0 expression may be explained by the observation that KOSand ATfi-infected ganglia yielded equivalent levels of infectious virus when titrated on L7 cells. Neurons therefore may be infected by ATfi viral particles which cannot complete an infectious cycle in mouse or Vero cells, but nevertheless contain an intact genome capable of establishing a reactivationcompetent latency.
Another non-mutually exclusive explanation for the reactivation competence of ATfi is that only a low level of ICP0 is necessary for efficient reactivation. Several studies are consistent with this idea. Firstly, Cai & Schaffer (1989) demonstrated that cotransfection of an ICP0-expressing plasmid with infectious DNA from an ICP0 null mutant virus in molar ratios of either 1 : 1 or 40:1 leads to partial complemenration by the initiation of new virus synthesis. Secondly, it has been shown that viral mutants which express reduced levels of thymidine kinase (Coen et aI., 1989) or LATs (Rader eta]., 1993) can reactivate with an efficiency comparable to wild-type virus. Another possibility is that regulation of ICP0 expression during reactivation is different than during acute infection. While the temporal order of gene expression during reactivation appears consistent with that observed in tissue culture (Kosz-Vnenchak eta], 1993), the regulation of IE genes has not been studied in neurons. Thirdly, the VPI6 activation domain is dispensable for reactivation, suggesting that IE gene regulation may differ in neurons (Steiner et al., 1990) . Fourthly, ICP0 is capable of transactivating its own promoter (Gelman & Silverstein, 1986 ) and a limited amount of ICP0 could help ATfi to transactivate its own promoter, allowing efficient reactivation.
In summary, this study shows that a number of cis-acting elements that have been mapped in cell culture are indeed important for ICPO expression, efficiency of plating in noncomplementing cells and also virulence. These elements, however, are dispensable for reactivation from latency in an explant reactivation model. It remains to be determined whether these elements can affect in viva reactivation efficiencies in other animal models. Future work will be focused upon the elucidation of the cis-acting elements and their cognate frans-acting factors which are required for activation of ICP0 and reactivation, a pivotal point in the virus' life cycle.
